You just read:

AstraZeneca, Pharmacyclics And Janssen Partner On Immuno-Oncology Combination Trials With IMBRUVICA® For Hematologic Cancers

News provided by

Pharmacyclics, Inc.

Nov 04, 2014, 08:00 ET